摘要
目的:探析美国医药产业政策体系的构成、主要内容与政策效果,凝练对我国医药产业政策体系完善的重要启示。方法:采用文献研究法,收集美国医药产业政策的制度、法案、资料和相关统计数据,进而剖析美国医药产业政策的体系的关键内容和政策效果。结论:美国医药产业政策目标明确、相互协同,药品管理严格细致,专利保护完善,极大促进了产业的创新发展,同时又能兼顾弱势群体的支付能力。这些对我国医药产业政策的完善具有重要启示。
Objective To explore the policy composition,main content and policy effect of American pharmaceutical industry policy system.And then to gain key enlightenment from it to improve and perfect Chinese pharmaceutical industry policy system.Methods To collect American pharmaceutical industry policy,laws,information and related statistical data by literature research,then to analyze the key content and policy effect of the policy system.Conclusion The policy system has clear goals,strict medicine management and good patent protection.It also works in concert.It greatly promotes the innovation and development of pharmaceutical industry.It considers the vulnerable groups' ability to pay as well.All these have important implications for perfecting Chinese pharmaceutical industry policy.
作者
李洁
王永辉
David Qian
LI Jie(School of Health and Economic Management,Nanjing University of Traditional Chinese Medicine,Nan-jing,P.R.Chin)
出处
《中国卫生事业管理》
北大核心
2018年第8期593-597,共5页
Chinese Health Service Management
基金
江苏省社会科学基金"江苏生物医药产业关键技术预见与创新战略选择研究"(14GLB007)
江苏省高校哲学社会科学基金"江苏生物医药创新集群演化机理与发展策略研究--基于CAS视角"(2016SJB790018)
关键词
医药产业政策体系
美国
启示
pharmaceutical industry policy system
the US
the enlightenment